Althea Wins $912K Contract to Develop Plasmid-Based HIV Vaccine for NIAD

Aug 29, 2006

NEW YORK (GenomeWeb News) – Althea Technologies said today that Advanced BioScience Laboratories has awarded it a cGMP manufacturing contract worth $911,549 to produce a DNA-based HIV-1 vaccine.

The multi-year contract is under a master agreement with the US National Institutes of Health and funded by the National Institute of Allergy and Infectious Diseases, Althea said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

WHO Panel Announced

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

Research Reproducibility Scores

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

Tests for All Diagnosed

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

This Week in Science

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.

Main menu